In humans, a Th1–Ifng response is a characteristic of cancer immune surveillance48, associated with Th1 CD4+ and CD8+ T cells which directly regulate tumour cell cytotoxicity or induce senescence, while indirectly polarizing innate immune cells towards tumour suppression20, 49. The gene discussed is CD8A; the disease is cancer.